Dr. Ho returned to Charles River in 2012 as Corporate Senior Vice President, Corporate Strategy and Chief Strategy Officer, after previously serving as the Company’s Corporate Senior Vice President, Corporate Strategy from 2006 to 2010. Prior to rejoining Charles River, Dr. Ho was President of Decision Resources Consulting.
Dr. Ho has more than 20 years of experience serving pharmaceutical, biotech, medical device and provider organizations in a variety of capacities including corporate and M&A strategy formulation, product commercialization, investment decision making, process reengineering and organizational redesign. He was previously a partner at Accenture in its Health and Life Sciences Practice where he led the Discovery and Early Development practice areas. Prior to joining Accenture, Dr. Ho spent five years as a partner in the Life Science Industry Group of Pittiglio Rabin Todd & McGrath, and eight years at McKinsey and Company.
Dr. Ho received an M.D. degree from Brown University School of Medicine, an M.B.A. from the Amos Tuck School at Dartmouth College and a B.S. in Biology and Molecular Genetics from the Massachusetts Institute of Technology. In addition, he received post graduate medical training at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School.